Louis Pilati, MD
Undersea and Hyperbaric Medicine · Miamisburg, OHNPI 1205886439
Payments from drug & device makers
Across 45 payments — averaging $1992.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Molnlycke Health Care AB$44K
- Urgo Medical North America, LLC$43K
- Integra Lifesciences Corporation$2K
- Medline Industries LP$149
- KCI USA, Inc.$116
- Smith+Nephew$106
- plus $168 from 3 others
What the payments were for
- Consulting fees$10,00022%
- Speaking & faculty fees$33,10073%
- Food & beverage$8782%
- Education$120%
- Other$1,6634%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Molnlycke Health Care AB | 3 | $43,988 |
| Urgo Medical North America, LLC | 18 | $43,332 |
| Integra Lifesciences Corporation | 9 | $1,782 |
| Medline Industries LP | 3 | $149 |
| KCI USA, Inc. | 4 | $116 |
| Smith+Nephew | 3 | $106 |
| Molnlycke Health Care US, LLC | 1 | $98 |
| Tactile Systems Technology Inc | 3 | $54 |
| Cashflow Solutions, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP$27,700
- URGOK2 (LONG) KIT$16,400
- UrgoK2$13,700
- DRAWTEX HYDROCONDUCTIVE WOUND DRESSING WITH LEVAFIBER 4X4$13,700
- Vashe$10,500
- Urgo K2$2,500
- CYTAL$1,162
- MICROMATRIX$501
- Hyalomatrix Wound Device$111
How this compares
Too few undersea and hyperbaric medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SsdSilver Sulfadiazine | 32 | $708 |
| Silver Sulfadiazine | 35 | $623 |
| Doxycycline Monohydrate | 31 | $493 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $212 |
| Cephalexin | 16 | $87 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Miamisburg
- Arti MasturzoCincinnati$227
- Vincent FerriniCleveland$179
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.